Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer - Related Studies

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

This study is ongoing, but not recruiting participants.

Study NCT00002475. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Breast Cancer
		Colorectal Cancer
		Kidney Cancer
		Lung Cancer
		Malignant Mesothelioma
		Pancreatic Cancer

2	Additional conditions recognized in this trial
		Breast Neoplasms
		Carcinoma, Renal Cell
		Colorectal Neoplasms
		Kidney Neoplasms
		Lung Neoplasms
		Mesothelioma
		Pancreatic Neoplasms

3	More general conditions related to this trial
		Adenocarcinoma
		Adenoma
		Breast Diseases
		Carcinoma
		Colonic Diseases
		Digestive System Diseases
		Digestive System Neoplasms
		Endocrine Gland Neoplasms
		Endocrine System Diseases
		Gastrointestinal Diseases
		Gastrointestinal Neoplasms
		Intestinal Diseases
		Intestinal Neoplasms
		Kidney Diseases
		Lung Diseases
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Glandular and Epithelial
		Neoplasms, Mesothelial
		Pancreatic Diseases
		Rectal Diseases
		Respiratory Tract Diseases
		Respiratory Tract Neoplasms
		Skin Diseases
		Thoracic Neoplasms
		Urogenital Neoplasms
		Urologic Diseases
		Urologic Neoplasms

4	Interventions listed in this trial
		allogeneic tumor cell vaccine
		autologous tumor cell vaccine
		cyclophosphamide
		recombinant interferon alfa
		recombinant interferon gamma
		sargramostim

5	Additional drug interventions recognized in this trial
		Interferon Alfa-2a
		Interferon Alfa-2b
		Interferon Type I, Recombinant
		Interferon Type II
		Interferon-alpha
		Interferon-gamma, Recombinant
		Interferons

6	More general drug interventions related to this trial
		Alkylating Agents
		Angiogenesis Inhibitors
		Angiogenesis Modulating Agents
		Anti-Infective Agents
		Antineoplastic Agents
		Antineoplastic Agents, Alkylating
		Antirheumatic Agents
		Antiviral Agents
		Growth Inhibitors
		Growth Substances
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Myeloablative Agonists
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

7	Sponsors listed in this trial
		St. Vincent Medical Center - Los Angeles